Limits...
Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.

Haddad O, Guyot E, Marinval N, Chevalier F, Maillard L, Gadi L, Laguillier-Morizot C, Oudar O, Sutton A, Charnaux N, Hlawaty H - Mar Drugs (2015)

Bottom Line: The phenotypic tests of LMWF-treated and EXT2- or HPSE-siRNA-transfected cells indicated that EXT2 or HPSE expression significantly affect the proangiogenic potential of LMWF.In addition, LMWF increased SDC-1, but decreased SDC-4 expressions.The effect of LMWF depends on SDC-4 expression.

View Article: PubMed Central - PubMed

Affiliation: Inserm U1148, Laboratory for Vascular Translational Science, UFR SMBH, Université Paris 13, Sorbonne Paris Cité, Groupe Biothérapies et Glycoconjugués, 93000 Bobigny, France. haddad.oualid@univ-paris13.fr.

ABSTRACT
Induction of angiogenesis is a potential treatment for chronic ischemia. Low molecular weight fucoidan (LMWF), the sulfated polysaccharide from brown seaweeds, has been shown to promote revascularization in a rat limb ischemia, increasing angiogenesis in vivo. We investigated the potential role of two heparan sulfate (HS) metabolism enzymes, exostosin-2 (EXT2) and heparanase (HPSE), and of two HS-membrane proteoglycans, syndecan-1 and -4 (SDC-1 and SDC-4), in LMWF induced angiogenesis. Our results showed that LMWF increases human vascular endothelial cell (HUVEC) migration and angiogenesis in vitro. We report that the expression and activity of the HS-degrading HPSE was increased after LMWF treatment. The phenotypic tests of LMWF-treated and EXT2- or HPSE-siRNA-transfected cells indicated that EXT2 or HPSE expression significantly affect the proangiogenic potential of LMWF. In addition, LMWF increased SDC-1, but decreased SDC-4 expressions. The effect of LMWF depends on SDC-4 expression. Silencing EXT2 or HPSE leads to an increased expression of SDC-4, providing the evidence that EXT2 and HPSE regulate the SDC-4 expression. Altogether, these data indicate that EXT2, HPSE, and SDC-4 are involved in the proangiogenic effects of LMWF, suggesting that the HS metabolism changes linked to LMWF-induced angiogenesis offer the opportunity for new therapeutic strategies of ischemic diseases.

Show MeSH

Related in: MedlinePlus

Assessment of EXT involvement in biological effects of LMWF in HUVECs. HUVECs were transfected with EXT1-siRNA or EXT2-siRNA or with SNC-siRNA control. (A) EXT1 or EXT2 mRNA levels were determined in EXT1-siRNA- or EXT2-siRNA- or SNC-siRNA-transfected control cell by real-time RT PCR. EXT1- or EXT2 mRNA level normalized to GAPDH mRNA level in SNC-siRNA-transfected control cells was arbitrarily set to 1; (B) The binding of 10E4 anti-HS antibodies to EXT2- or EXT1-siRNA transfected cells was compared to that of SNC-siRNA-transfected cells; (C) Migration was assayed in cells treated with or without 10 µg/mL LMWF; (D) 2D-angiogenesis was assayed in cells treated with or without 10 µg/mL LMWF. The difference in the capillary network length between LMWF-treated and untreated cells in each RNA interference condition (EXT1 or EXT2 silencing) was compared to that in SNC-siRNA-transfected cells. Control LMWF induction was arbitrary set at 100% for SNC-siRNA-transfected cells. * p < 0.05, *** p < 0.0005 versus SNC-siRNA-transfected control cells. A.U.: arbitrary unit.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4663543&req=5

marinedrugs-13-06588-f006: Assessment of EXT involvement in biological effects of LMWF in HUVECs. HUVECs were transfected with EXT1-siRNA or EXT2-siRNA or with SNC-siRNA control. (A) EXT1 or EXT2 mRNA levels were determined in EXT1-siRNA- or EXT2-siRNA- or SNC-siRNA-transfected control cell by real-time RT PCR. EXT1- or EXT2 mRNA level normalized to GAPDH mRNA level in SNC-siRNA-transfected control cells was arbitrarily set to 1; (B) The binding of 10E4 anti-HS antibodies to EXT2- or EXT1-siRNA transfected cells was compared to that of SNC-siRNA-transfected cells; (C) Migration was assayed in cells treated with or without 10 µg/mL LMWF; (D) 2D-angiogenesis was assayed in cells treated with or without 10 µg/mL LMWF. The difference in the capillary network length between LMWF-treated and untreated cells in each RNA interference condition (EXT1 or EXT2 silencing) was compared to that in SNC-siRNA-transfected cells. Control LMWF induction was arbitrary set at 100% for SNC-siRNA-transfected cells. * p < 0.05, *** p < 0.0005 versus SNC-siRNA-transfected control cells. A.U.: arbitrary unit.

Mentions: Quantitative RT-PCR showed that the expression of the mRNAs and proteins of EXT2 in EXT2-siRNA- and EXT1 in EXT1-siRNA-transfected cells was reduced up to 72% ± 16% and 71% ± 15%, respectively, as compared to the SNC-siRNA-transfected control cells (Figure 6A). The flow cytometry assay showed that the binding of 10E4 anti-HS antibodies to EXT2-siRNA- or EXT1-siRNA-transfected cells was respectively reduced by 75% ± 8% or by 80% ± 9%, as compared to SNC-siRNA-transfected control cells (Figure 6B).


Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.

Haddad O, Guyot E, Marinval N, Chevalier F, Maillard L, Gadi L, Laguillier-Morizot C, Oudar O, Sutton A, Charnaux N, Hlawaty H - Mar Drugs (2015)

Assessment of EXT involvement in biological effects of LMWF in HUVECs. HUVECs were transfected with EXT1-siRNA or EXT2-siRNA or with SNC-siRNA control. (A) EXT1 or EXT2 mRNA levels were determined in EXT1-siRNA- or EXT2-siRNA- or SNC-siRNA-transfected control cell by real-time RT PCR. EXT1- or EXT2 mRNA level normalized to GAPDH mRNA level in SNC-siRNA-transfected control cells was arbitrarily set to 1; (B) The binding of 10E4 anti-HS antibodies to EXT2- or EXT1-siRNA transfected cells was compared to that of SNC-siRNA-transfected cells; (C) Migration was assayed in cells treated with or without 10 µg/mL LMWF; (D) 2D-angiogenesis was assayed in cells treated with or without 10 µg/mL LMWF. The difference in the capillary network length between LMWF-treated and untreated cells in each RNA interference condition (EXT1 or EXT2 silencing) was compared to that in SNC-siRNA-transfected cells. Control LMWF induction was arbitrary set at 100% for SNC-siRNA-transfected cells. * p < 0.05, *** p < 0.0005 versus SNC-siRNA-transfected control cells. A.U.: arbitrary unit.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4663543&req=5

marinedrugs-13-06588-f006: Assessment of EXT involvement in biological effects of LMWF in HUVECs. HUVECs were transfected with EXT1-siRNA or EXT2-siRNA or with SNC-siRNA control. (A) EXT1 or EXT2 mRNA levels were determined in EXT1-siRNA- or EXT2-siRNA- or SNC-siRNA-transfected control cell by real-time RT PCR. EXT1- or EXT2 mRNA level normalized to GAPDH mRNA level in SNC-siRNA-transfected control cells was arbitrarily set to 1; (B) The binding of 10E4 anti-HS antibodies to EXT2- or EXT1-siRNA transfected cells was compared to that of SNC-siRNA-transfected cells; (C) Migration was assayed in cells treated with or without 10 µg/mL LMWF; (D) 2D-angiogenesis was assayed in cells treated with or without 10 µg/mL LMWF. The difference in the capillary network length between LMWF-treated and untreated cells in each RNA interference condition (EXT1 or EXT2 silencing) was compared to that in SNC-siRNA-transfected cells. Control LMWF induction was arbitrary set at 100% for SNC-siRNA-transfected cells. * p < 0.05, *** p < 0.0005 versus SNC-siRNA-transfected control cells. A.U.: arbitrary unit.
Mentions: Quantitative RT-PCR showed that the expression of the mRNAs and proteins of EXT2 in EXT2-siRNA- and EXT1 in EXT1-siRNA-transfected cells was reduced up to 72% ± 16% and 71% ± 15%, respectively, as compared to the SNC-siRNA-transfected control cells (Figure 6A). The flow cytometry assay showed that the binding of 10E4 anti-HS antibodies to EXT2-siRNA- or EXT1-siRNA-transfected cells was respectively reduced by 75% ± 8% or by 80% ± 9%, as compared to SNC-siRNA-transfected control cells (Figure 6B).

Bottom Line: The phenotypic tests of LMWF-treated and EXT2- or HPSE-siRNA-transfected cells indicated that EXT2 or HPSE expression significantly affect the proangiogenic potential of LMWF.In addition, LMWF increased SDC-1, but decreased SDC-4 expressions.The effect of LMWF depends on SDC-4 expression.

View Article: PubMed Central - PubMed

Affiliation: Inserm U1148, Laboratory for Vascular Translational Science, UFR SMBH, Université Paris 13, Sorbonne Paris Cité, Groupe Biothérapies et Glycoconjugués, 93000 Bobigny, France. haddad.oualid@univ-paris13.fr.

ABSTRACT
Induction of angiogenesis is a potential treatment for chronic ischemia. Low molecular weight fucoidan (LMWF), the sulfated polysaccharide from brown seaweeds, has been shown to promote revascularization in a rat limb ischemia, increasing angiogenesis in vivo. We investigated the potential role of two heparan sulfate (HS) metabolism enzymes, exostosin-2 (EXT2) and heparanase (HPSE), and of two HS-membrane proteoglycans, syndecan-1 and -4 (SDC-1 and SDC-4), in LMWF induced angiogenesis. Our results showed that LMWF increases human vascular endothelial cell (HUVEC) migration and angiogenesis in vitro. We report that the expression and activity of the HS-degrading HPSE was increased after LMWF treatment. The phenotypic tests of LMWF-treated and EXT2- or HPSE-siRNA-transfected cells indicated that EXT2 or HPSE expression significantly affect the proangiogenic potential of LMWF. In addition, LMWF increased SDC-1, but decreased SDC-4 expressions. The effect of LMWF depends on SDC-4 expression. Silencing EXT2 or HPSE leads to an increased expression of SDC-4, providing the evidence that EXT2 and HPSE regulate the SDC-4 expression. Altogether, these data indicate that EXT2, HPSE, and SDC-4 are involved in the proangiogenic effects of LMWF, suggesting that the HS metabolism changes linked to LMWF-induced angiogenesis offer the opportunity for new therapeutic strategies of ischemic diseases.

Show MeSH
Related in: MedlinePlus